Editors Overview

tdd maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue

CRISPR-Cas9 for therapeutic nanoparticle delivery

Abstract Submission Deadline : November 30, 2024

Manuscript Submission Deadline : December 25, 2024

Special Issue Description

A possible method for manipulating the genome is the newly developed clustered regularly interspersed short palindromic repeat (CRISPR)/CRISPR-associated system (Cas) gene-editing technology. However, the utilization and efficacy of this compound for therapeutic applications are substantially compromised by its low intracellular transport efficiency. Sometimes referred to as “God’s scalpel,” gene editing technology may precisely and successfully cut, replace, or insert DNA or RNA sequences. This ground-breaking method can be used for diagnosis and treatment, in vivo gene therapy, animal modeling, and modified cell therapies.


Genome editing, CRISPR-Cas9, Genome manipulation, God’s Scalpel

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals:






950 $